{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:38:04Z","timestamp":1787164684832,"version":"build-2736575974"},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ijtb.2016.06.003","type":"journal-article","created":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T18:00:24Z","timestamp":1481824824000},"page":"44-46","source":"Crossref","is-referenced-by-count":14,"title":["Black brown discoloration and hairy tongue \u2013 A rare linezolid side effect"],"prefix":"10.1016","volume":"64","author":[{"given":"A.K.","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Mohan","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijtb.2016.06.003_bib0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/11319960-000000000-00000","article-title":"Pharmacological issues of linezolid: an updated critical review","volume":"49","author":"Di Paolo","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijtb.2016.06.003_bib0065","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1086\/379012","article-title":"Linezolid-associated toxic optic neuropathy: a report of 2 cases","volume":"37","author":"Lee","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijtb.2016.06.003_bib0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.diagmicrobio.2008.08.009","article-title":"Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey","volume":"62","author":"Beekmann","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijtb.2016.06.003_bib0075","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0732-8893(91)90002-W","article-title":"Oxazolidinones, a new class of synthetic antituberculosis agent: in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis","volume":"14","author":"Ashtekar","year":"1991","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijtb.2016.06.003_bib0080","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/jm950956y","article-title":"Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity","volume":"39","author":"Barbachyn","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijtb.2016.06.003_bib0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijantimicag.2006.02.011","article-title":"In vitro activity of linezolid against Mycobacterium tuberculosis complex, including multidrug-resistant Mycobacterium bovis isolates","volume":"28","author":"Tato","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijtb.2016.06.003_bib0090","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/AAC.40.4.839","article-title":"In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents","volume":"40","author":"Zurenko","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 1","key":"10.1016\/j.ijtb.2016.06.003_bib0095","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0163-4453(09)60009-8","article-title":"Linozolid a review of safety and tolerability","volume":"59","author":"Vinh","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.ijtb.2016.06.003_bib0100","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1592\/phco.30.6.585","article-title":"Drug-induced black hairy tongue","volume":"30","author":"Thompson","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijtb.2016.06.003_bib0105","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3949\/ccjm.75a.08023","article-title":"Black hairy tongue","volume":"75","author":"Van\u00f3-Galv\u00e1n","year":"2008","journal-title":"Clevel Clin J Med"},{"issue":"June (6)","key":"10.1016\/j.ijtb.2016.06.003_bib0110","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.amjmed.2008.02.023","article-title":"Linezolid-induced lingua villosanigra","volume":"121","author":"Refaat","year":"2008","journal-title":"Am J Med"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570715300202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570715300202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T12:14:26Z","timestamp":1568636066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570715300202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0019570715300202"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2016.06.003","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}